Result Summary for 101468/062
| Protocol ID: | 101468/062 |
| Clinical Study ID: | SK&F 101468/062 |
| Official Title: | An open study to assess the pharmacokinetic interaction at steady state following multiple oral dosing, between Ropinirole (2 MG TDS) and L-Dopa (100 MG BD) (+ Decarboxylase Inhibitor) in L-Dopa naïve (De Novo) patients with Parkinson’s disease. |
| Phase: | Phase 2 |
| Study Indications or Diseases: |
|
| Generic Name: | ropinirole |
| Trade/Product Name: | requip;requip |
| Approved Drug Label: | http://www.gsk.com/products.html |
| Results Summary: |  Click
here to download result summary. |
| Citations: |
|
The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.
